Elevation Oncology Inc. (ELEV)
0.62
0.01 (2.34%)
At close: Jan 28, 2025, 3:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -45.70M | -95.08M | -32.04M | -17.27M | -5.88M |
| Depreciation & Amortization | 39.00K | 27.00K | 18.00K | 15.00K | n/a |
| Stock-Based Compensation | 3.33M | 3.21M | 1.57M | 52.00K | 13.50K |
| Other Working Capital | -7.83M | 5.58M | 313.00K | -319.00K | -37.00K |
| Other Non-Cash Items | -160.00K | 74.00K | 1.64M | -5.14M | -451.00K |
| Deferred Income Tax | n/a | n/a | -1.64M | 5.14M | n/a |
| Change in Working Capital | -13.69M | 6.29M | 283.00K | 4.90M | 423.00K |
| Operating Cash Flow | -56.18M | -85.48M | -30.17M | -12.30M | -5.45M |
| Capital Expenditures | n/a | -86.00K | n/a | -71.00K | n/a |
| Acquisitions | n/a | 44.31K | n/a | n/a | n/a |
| Purchase of Investments | -42.66M | -112.31M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 54.20M | 68.00M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -44.31K | n/a | n/a | n/a |
| Investing Cash Flow | 11.54M | -44.40M | n/a | -71.00K | n/a |
| Debt Repayment | n/a | 30.00M | n/a | n/a | n/a |
| Common Stock Repurchased | -24.00K | -35.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.50M | -451.00K | -11.00K | 90.01M | 10.79M |
| Financial Cash Flow | 47.98M | 29.51M | 97.05M | 90.03M | 7.19M |
| Net Cash Flow | 3.34M | -100.37M | 66.88M | 77.66M | 1.74M |
| Free Cash Flow | -56.18M | -85.57M | -30.17M | -12.37M | -5.45M |